Search Results - "Hvass, Lars"

Development of 18F-Labeled Bispyridyl Tetrazines for In Vivo Pretargeted PET Imaging by García-Vázquez, Rocío, Jørgensen, Jesper Tranekjær, Bratteby, Klas Erik, Shalgunov, Vladimir, Hvass, Lars, Herth, Matthias M., Kjær, Andreas, Battisti, Umberto Maria

“…Pretargeted PET imaging is an emerging and fast-developing method to monitor immuno-oncology strategies. Currently, tetrazine ligation is considered the most…”
Get full text

Lipophilicity and Click Reactivity Determine the Performance of Bioorthogonal Tetrazine Tools in Pretargeted In Vivo Chemistry by Stéen, E. Johanna L, Jørgensen, Jesper T, Denk, Christoph, Battisti, Umberto M, Nørregaard, Kamilla, Edem, Patricia E, Bratteby, Klas, Shalgunov, Vladimir, Wilkovitsch, Martin, Svatunek, Dennis, Poulie, Christian B. M, Hvass, Lars, Simón, Marina, Wanek, Thomas, Rossin, Raffaella, Robillard, Marc, Kristensen, Jesper L, Mikula, Hannes, Kjaer, Andreas, Herth, Matthias M

“…The development of highly selective and fast biocompatible reactions for ligation and cleavage has paved the way for new diagnostic and therapeutic…”
Get full text

Development of Polar BODIPY-Tetrazines for Rapid Pretargeted Fluorescence Imaging by Staudt, Markus, Hvass, Lars, Müller, Marius, García-Vázquez, Rocío, Jo̷rgensen, Jesper Tranekjær, Shalgunov, Vladimir, Battisti, Umberto Maria, Kjær, Andreas, Herth, Matthias M.

“…Polar BODIPY-tetrazine dyes were developed and clicked in vivo to a preaccumulated trans-cyclooctene-modified anti-TAG72 monoclonal antibody CC49 (CC49-TCO)…”
Get full text

[ 68 Ga]Ga-DOTAGA-Glu(FAPi) 2 Shows Enhanced Tumor Uptake and Theranostic Potential in Preclinical PET Imaging by Mortensen, Julie van Krimpen, Mattiussi, Simona, Hvass, Lars, Lund, Emilie Graae, Shalgunov, Vladimir, Roesch, Frank, Battisti, Umberto Maria, Herth, Matthias Manfred, Kjaer, Andreas

“…The use of fibroblast activation protein inhibitors (FAPis) for positron emission tomography (PET) imaging in cancer has garnered significant interest in…”
Get full text

Development of BODIPY-Tetrazines as Pretargeted Bimodal Fluorescent-Radioactive Tracers by Herth, Matthias, Staudt, Markus, Hvass, Lars, Müller, Marius, Jørgensen, Jesper, Vázquez, Rocío García, Kjær, Andreas

Get full text

Development of five Polar and Highly Reactive Tetrazines for Pretargeted Imaging by Müller, Marius, Hvass, Lars, Jørgensen, Jesper, Battisti, Umberto, Staudt, Markus, Vázquez, Rocío García, Shalgunov, Vladimir, Kjær, Andreas, Herth, Matthias

Get full text

Abstract 6034: PSMA targeted alpha radiopharmaceutical [211At]PSAt-3 inhibits tumor growth in a preclinical model of prostate cancer by Hvass, Lars, Müller, Marius, Clausen, Anne, Herth, Matthias, Kjaer, Andreas

“…Abstract Introduction: Prostate cancer continues to be a highly prevalent cancer diagnosis among men and a leading cause of cancer related deaths worldwide…”
Get full text

Development of 11C-Tucatinib as a potential HER2-targeting PET radiotracer by Müller, Marius, Battisti, Umberto, Shalgunov, Vladimir, Jørgensen, Jesper, Hvass, Lars, Kramer, Vasko, Kjær, Andreas, Herth, Matthias

Get full text

P-287 - Development of 11C-Tucatinib as a potential HER2-targeting PET radiotracer by Müller, Marius, Battisti, Umberto, Shalgunov, Vladimir, Jørgensen, Jesper, Hvass, Lars, Kramer, Vasko, Kjær, Andreas, Herth, Matthias

Get full text

Extracorporeal clearing traps based on tetrazine ligation for pretargeted therapy and diagnostics by Shalgunov, Vladimir, Hvass, Lars, Jørgensen, Jesper, Poulie, Christian, Johann, Kerstin, Barz, Matthias, Kjær, Andreas, Herth, Matthias

Get full text

P-299 - Extracorporeal clearing traps based on tetrazine ligation for pretargeted therapy and diagnostics by Shalgunov, Vladimir, Hvass, Lars, Jørgensen, Jesper, Poulie, Christian, Johann, Kerstin, Barz, Matthias, Kjær, Andreas, Herth, Matthias

Get full text

Development of the First Aliphatic 18F‑Labeled Tetrazine Suitable for Pretargeted PET ImagingExpanding the Bioorthogonal Tool Box by Battisti, Umberto M, Bratteby, Klas, Jørgensen, Jesper T, Hvass, Lars, Shalgunov, Vladimir, Mikula, Hannes, Kjær, Andreas, Herth, Matthias Manfred

“…Pretargeted imaging of nanomedicines have attracted considerable interest because it has the potential to increase imaging contrast while reducing radiation…”
Get full text

Development of aliphatic 18F-labeled tetrazines suitable for pretargeted PET imaging by Battisti, Umberto, Bratteby, Klas, Vázquez, Rocío García, Jørgensen, Jesper, Shalgunov, Vladimir, Hvass, Lars, Kjær, Andreas, Herth, Matthias

Get full text

P-237 - Development of aliphatic 18F-labeled tetrazines suitable for pretargeted PET imaging by Battisti, Umberto, Bratteby, Klas, Vázquez, Rocío García, Jørgensen, Jesper, Shalgunov, Vladimir, Hvass, Lars, Kjær, Andreas, Herth, Matthias

Get full text

Development of the First Aliphatic 18 F-Labeled Tetrazine Suitable for Pretargeted PET Imaging-Expanding the Bioorthogonal Tool Box by Battisti, Umberto M, Bratteby, Klas, Jørgensen, Jesper T, Hvass, Lars, Shalgunov, Vladimir, Mikula, Hannes, Kjær, Andreas, Herth, Matthias Manfred

“…Pretargeted imaging of nanomedicines have attracted considerable interest because it has the potential to increase imaging contrast while reducing radiation…”
Get full text

Development and Preclinical Evaluation of [211At]PSAt-3-Ga: An Inhibitor for Targeted a-Therapy of Prostate Cancer by El Fakiri, Mohamed, Ayada, Nawal, Mueller, Marius, Hvass, Lars, Gamzov, Teodor H., Clausen, Anne Skovsbo, Geis, Nicolas M., Steinacker, Nils, Hansson, Ellinor, Lindegren, Sture, Aneheim, Emma, Jensen, Holger, Eder, Ann-Christin, Jensen, Andreas I., Poulie, Christian B. M., Kjaer, Andreas, Eder, Matthias, Herth, Matthias M.

“…The application of prostate -specific membrane antigen (PSMA)- targeted a -therapy is a promising alternative to b 2 -particle-based treatments. 211 At is…”
Get full text

Synthesis and in vivo evaluation of [11C]tucatinib for HER2-targeted PET imaging by Müller, Marius, Shalgunov, Vladimir, Hvass, Lars, Jørgensen, Jesper T., Kramer, Vasko, Staudt, Markus, Battisti, Umberto Maria, Kjaer, Andreas, Herth, Matthias M.

“…[Display omitted] •[11C]tucatinib was designed and synthesized as a HER2 PET imaging agent•The compound was obtained in a 12 steps synthetic…”
Get full text

Development and Preclinical Evaluation of [ 211 At]PSAt-3-Ga: An Inhibitor for Targeted α-Therapy of Prostate Cancer by El Fakiri, Mohamed, Ayada, Nawal, Müller, Marius, Hvass, Lars, Gamzov, Teodor H, Clausen, Anne Skovsbo, Geis, Nicolas M, Steinacker, Nils, Hansson, Ellinor, Lindegren, Sture, Aneheim, Emma, Jensen, Holger, Eder, Ann-Christin, Jensen, Andreas I, Poulie, Christian B M, Kjaer, Andreas, Eder, Matthias, Herth, Matthias M

“…The application of prostate-specific membrane antigen (PSMA)-targeted α-therapy is a promising alternative to β -particle-based treatments. At is among the…”
Get full text

Bioorthogonal Click of Colloidal Gold Nanoparticles to Antibodies In vivo by Poulie, Christian B. M., Sporer, Emanuel, Hvass, Lars, Jørgensen, Jesper T., Kempen, Paul J., Lopes van den Broek, Sara I., Shalgunov, Vladimir, Kjaer, Andreas, Jensen, Andreas I., Herth, Matthias M.

“…Combining nanotechnology and bioorthogonal chemistry for theranostic strategies offers the possibility to develop next generation nanomedicines. These…”
Get full text

Optimized QMA-elution enables direct aliphatic 18F-fluorination of highly reactive tetrazines for pretargeted imaging by Bratteby, Klas, Battisti, Umberto, Vázquez, Rocío García, Shalgunov, Vladimir, Jørgensen, Jesper, Hvass, Lars, van den Broek, Sara Lopes, Petersen, Ida, Erlandsson, Maria, Ohlsson, Tomas, Gillings, Nic, Mikula, Hannes, Kjær, Andreas, Herth, Matthias

Get full text